Berlie J, Tournade M F, Chauvergne J, Bastien H
Bull Cancer. 1983;70(1):14-21.
With 2 436 deaths in 1979, ovarian cancer is relatively infrequent in France comprising but 5 per cent of female mortality from malignant disease. However, the rate of increase in mortality is considerable, 70 per cent between 1955 and 1979 or 2,9 per cent per year, greater than that for female bladder and breast cancer. The estimated morbidity and mortality rates (age-adjusted to the world standard population) were 7,5 and 5,4 per 100,000 per annum respectively for 1979, figures in the mid range of international data. This is situated below the rates observed in Scandinavia and North America which occupied the first ranks. The high proportion of metastatic dissemination (55%) at the time of diagnosis and the variety of morphological types (80% being epithelial cancers) emerges from clinical data relating to a series of 2,937 ovarian cancers diagnosed by the "Enquête Permanente Cancer". The 5-year survival rate was 13 per cent with only 50 per cent being alive at the end of the first year. To improve these poor results it is necessary to identify new risk factors in a future French epidemiological study using case control and prospective approaches.
1979年，法国有2436人死于卵巢癌，卵巢癌在法国相对并不常见，仅占女性恶性疾病死亡率的5%。然而，死亡率的增长速度相当可观，1955年至1979年间增长了70%，即每年增长2.9%，高于女性膀胱癌和乳腺癌的死亡率增长速度。1979年，经年龄调整至世界标准人口后的估计发病率和死亡率分别为每年每10万人7.5例和5.4例，这一数字处于国际数据的中等范围。该数字低于斯堪的纳维亚和北美地区观察到的发病率和死亡率，这些地区位居前列。根据“永久性癌症调查”诊断的一系列2937例卵巢癌的临床数据显示，诊断时转移扩散的比例很高（55%），形态学类型多样（80%为上皮癌）。5年生存率为13%，第一年结束时只有50%的患者存活。为了改善这些糟糕的结果，有必要在未来的法国流行病学研究中采用病例对照和前瞻性方法来识别新的风险因素。
